Signaling pathways
-
F1822 Anti-TNFRSF5/CD40 Antibody (Cifurtilimab)Summary: Anti-TNFRSF5/CD40 Antibody (Cifurtilimab) -
F1823 Anti-TNFSF5/CD40L/CD154 Antibody (Dapirolizumab)Summary: Anti-TNFSF5/CD40L/CD154 Antibody (Dapirolizumab) -
F1824 Anti-MAGE-A4 Antibody (Imc-C103C)Summary: Anti-MAGE-A4 Antibody (Imc-C103C) -
F1825 Anti-NGF/bNGF Antibody (Izenivetmab)Summary: Anti-NGF/bNGF Antibody (Izenivetmab) -
F1826 Anti-S100A4 Antibody (LK-1)Summary: Anti-S100A4 Antibody (LK-1) -
F1827 Anti-Klotho Beta Antibody (NGM313)Summary: Anti-Klotho Beta Antibody (NGM313) -
F1828 Anti-MER/MERTK Antibody (RGX-019)Summary: Anti-MER/MERTK Antibody (RGX-019) -
F1829 Anti-LAP Antibody (Brigham and Womens anti-LAP)Summary: Anti-LAP Antibody (Brigham and Womens anti-LAP) -
F1830 Anti-LILRB4/ILT3/CD85k Antibody (Merck patent anti-ILT3 complex)Summary: Anti-LILRB4/ILT3/CD85k Antibody (Merck patent anti-ILT3 complex) -
F1831 Anti-LILRB4/ILT3/CD85k Antibody (U.Texas patent anti-LILRB4)Summary: Anti-LILRB4/ILT3/CD85k Antibody (U.Texas patent anti-LILRB4)